000 | 01887 a2200517 4500 | ||
---|---|---|---|
005 | 20250518060756.0 | ||
264 | 0 | _c20201111 | |
008 | 202011s 0 0 eng d | ||
022 | _a1532-2939 | ||
024 | 7 |
_a10.1016/j.jhin.2019.09.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, C H | |
245 | 0 | 0 |
_aLevofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients. _h[electronic resource] |
260 |
_bThe Journal of hospital infection _cJan 2020 |
||
300 |
_a46-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aCeftazidime _xpharmacology |
650 | 0 | 4 |
_aColistin _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluoroquinolones _xadverse effects |
650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntensive Care Units _xstatistics & numerical data |
650 | 0 | 4 |
_aLevofloxacin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStenotrophomonas maltophilia _xdrug effects |
650 | 0 | 4 |
_aTaiwan _xepidemiology |
650 | 0 | 4 |
_aTigecycline _xpharmacology |
650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xpharmacology |
700 | 1 | _aYu, C-M | |
700 | 1 | _aHsu, S-T | |
700 | 1 | _aWu, R-X | |
773 | 0 |
_tThe Journal of hospital infection _gvol. 104 _gno. 1 _gp. 46-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhin.2019.09.001 _zAvailable from publisher's website |
999 |
_c30096511 _d30096511 |